ARTICLE

FindCenter AddIcon

Well Woman Interview: Natalie Lyla Ginsberg

By Tonya Papanikolov

MAPS is a non-profit research and educational organization based in California that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. Natalie’s work takes her around the world, from speaking to conservative medical professionals to representing MAPS at the United Nations Commission on Narcotic Drugs where passionate and diverse professionals gather to end the drug war.

Read on thewellwoman.co

FindCenter Post-Image

An Introduction to MDMA

Once considered the quintessential party drug, MDMA (also known as “ecstasy,” “X,” or “molly”) is now experiencing a surge of interest in a completely different area: psychedelic-assisted psychotherapy.

FindCenter AddIcon
FindCenter Post-Image

An Introduction to LSD

LSD, or lysergic acid diethylamide, is a synthetic drug with potent psychedelic properties. Commonly known as acid, it was originally derived from compounds found in ergot, a fungus that grows on rye.

FindCenter AddIcon
FindCenter Post-Image

A Brief History of Psychedelic Psychiatry

In the 1950s a group of pioneering psychiatrists showed that hallucinogenic drugs had therapeutic potential, but the research was halted as part of the backlash against the hippy counterculture.

FindCenter AddIcon
FindCenter Post-Image

Is It Self-Care, or Is It Capitalism?

So many of the little rituals I have each day—like my makeup or skincare routine—do help soothe and/or rejuvenate me. For me, any type of solo practiced routine is good. But I’ve learned that self-care does not, and cannot, sustain me. And I believe that this may be the case for many of you.

FindCenter AddIcon
FindCenter Post-Image

Inside The Movement To Decolonize Psychedelic Pharma

As Western medicine brings psychedelics into mainstream use, a growing movement is innovating new business models grounded in reciprocity and inclusion.

FindCenter AddIcon
FindCenter Post-Image

Françoise Bourzat: Consciousness Guide, Author, and Entheogenic Explorer

For those psychedelic users who experience post-use “spiritual comedowns”, psychedelic withdrawals, or a general sense of dopamine depletion, what can be done to alleviate these symptoms?

FindCenter AddIcon
FindCenter Post-Image

Psychedelic Therapy and Racial Trauma: Offering Clients a Deeper Experience of Healing

Like most people of color in the United States, psychotherapist and researcher Monnica Williams has experienced myriad forms of racism. Early in her career, understanding its effects on her mind and body motivated her to help clients address their own racial trauma in therapy.

FindCenter AddIcon
FindCenter Post-Image

The Cost of Exclusion in Psychedelic Research

In the last two decades, researchers have started to reexamine psychedelics for their therapeutic potential. Though initial results seem promising, the research has a significant shortcoming: the lack of racial and ethnic diversity among research teams and study participants.

FindCenter AddIcon
FindCenter Post-Image

Psychedelic Psychotherapy Is Coming: Who Will Be Included?

A new study finds widespread exclusion of minorities in psychedelic research.

FindCenter AddIcon
FindCenter Post-Image

How Researchers and Advocates of Color Are Forging Their Own Paths in Psychedelic-Assisted Therapy

We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.

FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research